InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Franson Timothy R, Director. Director active across 2 companies, notably Cidara Therapeutics, Inc.. In total, 4 disclosures have been logged. Total volume traded: €25k. The latest transaction was disclosed on 16 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
020,000 shares0
Common Stock
SEC:0000904454-22-000165·
020,000 shares0
Common Stock
SEC:0000904454-22-000165:0·
€12,5497,000 shares@ €1.7927100.0% of flow
Common Stock
SEC:0001610618-21-000084·
Ideal exit: 10 Jun 2022 (T+270)
€12,5497,000 shares@ €1.792750.0% of flow
Common Stock
SEC:0001610618-21-000084:0·
Ideal exit: 10 Jun 2022 (T+270)
4 of 4 declarations
About Franson Timothy R
Timothy R. Franson is a Board Member at Cidara Therapeutics, Inc. and Paratek Pharmaceuticals, Inc. He brings his expertise to the board, contributing to strategic decision-making for these companies. His role includes overseeing operations and protecting shareholder interests. Through his experience, he helps guide the future direction of the companies.
